Targeted Inhibition of Nuclear Factor-κB Pathway Using Recombinant Adeno-Associated Virus 5 in 2D and 3D Glioblastoma Models.
- DOI
- 10.1007/s12195-026-00924-y
- Published
- 2026 Aug
- Container
- Cellular and molecular bioengineering
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12195-026-00924-y,
title = {Targeted Inhibition of Nuclear Factor-κB Pathway Using Recombinant Adeno-Associated Virus 5 in 2D and 3D Glioblastoma Models.},
author = {Manikandan C and Ravi NS and M Kumarasamypet M and Jaiswal AK},
year = {2026},
journal = {Cellular and molecular bioengineering},
doi = {10.1007/s12195-026-00924-y},
url = {https://doi.org/10.1007/s12195-026-00924-y}
}RIS
TY - JOUR TI - Targeted Inhibition of Nuclear Factor-κB Pathway Using Recombinant Adeno-Associated Virus 5 in 2D and 3D Glioblastoma Models. AU - Manikandan C AU - Ravi NS AU - M Kumarasamypet M AU - Jaiswal AK PY - 2026 JO - Cellular and molecular bioengineering DO - 10.1007/s12195-026-00924-y UR - https://doi.org/10.1007/s12195-026-00924-y ER -
APA
C, M., NS, R., M, M. K., & AK, J. (2026). Targeted Inhibition of Nuclear Factor-κB Pathway Using Recombinant Adeno-Associated Virus 5 in 2D and 3D Glioblastoma Models.. Cellular and molecular bioengineering. https://doi.org/10.1007/s12195-026-00924-y
Source records
- pubmed · retrieved 2026-09-25T21:01:45.097Z